Dana Investment Advisors Inc. grew its stake in AMERISAFE, Inc. (NASDAQ:AMSF – Free Report) by 11.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,150 shares of the insurance provider’s stock after buying an additional 9,902 shares during the period. Dana Investment Advisors Inc. owned approximately 0.52% of AMERISAFE worth $4,396,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Public Employees Retirement Association of Colorado grew its position in AMERISAFE by 4.3% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 301,819 shares of the insurance provider’s stock worth $14,119,000 after acquiring an additional 12,433 shares in the last quarter. Westwood Holdings Group Inc. boosted its holdings in shares of AMERISAFE by 18.4% in the 4th quarter. Westwood Holdings Group Inc. now owns 678,321 shares of the insurance provider’s stock worth $31,732,000 after purchasing an additional 105,414 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of AMERISAFE by 26.9% during the 4th quarter. PNC Financial Services Group Inc. now owns 3,901 shares of the insurance provider’s stock valued at $182,000 after purchasing an additional 828 shares during the last quarter. Diversified Trust Co lifted its position in AMERISAFE by 32.2% in the 1st quarter. Diversified Trust Co now owns 7,361 shares of the insurance provider’s stock worth $369,000 after buying an additional 1,792 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in AMERISAFE by 209.8% in the first quarter. Allspring Global Investments Holdings LLC now owns 5,508 shares of the insurance provider’s stock worth $276,000 after buying an additional 3,730 shares in the last quarter. Institutional investors own 97.41% of the company’s stock.
AMERISAFE Price Performance
Shares of AMSF stock opened at $49.45 on Wednesday. The business has a 50-day moving average of $48.30 and a 200 day moving average of $46.95. AMERISAFE, Inc. has a 1-year low of $41.97 and a 1-year high of $54.80. The stock has a market capitalization of $946.23 million, a PE ratio of 15.40 and a beta of 0.34.
AMERISAFE Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 2.99%. The ex-dividend date of this dividend was Friday, September 6th. AMERISAFE’s dividend payout ratio (DPR) is 46.11%.
Analyst Ratings Changes
AMSF has been the topic of several research reports. JMP Securities reissued a “market outperform” rating and set a $65.00 price target on shares of AMERISAFE in a research note on Tuesday, July 30th. StockNews.com upgraded shares of AMERISAFE from a “sell” rating to a “hold” rating in a research report on Thursday, August 8th.
View Our Latest Stock Report on AMERISAFE
About AMERISAFE
AMERISAFE, Inc, an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Further Reading
- Five stocks we like better than AMERISAFE
- Options Trading – Understanding Strike Price
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is Insider Trading? What You Can Learn from Insider Trading
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.